It even raises the possibility that TRKBT695I and TRKBD751N may act in a dominant negative fashion, and that wild type TRKB may also have tumor suppressing activity (or a dual function) in colon cancer, but further studies will be required to address these important issues. This evidence concerns the gene NTRK2 and colonic neoplasm.